Bellevue Group’s NewAmsterdam Pharma NAMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$372K Sell
20,555
-1,245
-6% -$22.5K 0.01% 112
2025
Q1
$446K Sell
21,800
-3,200
-13% -$65.5K 0.01% 119
2024
Q4
$643K Buy
25,000
+17,300
+225% +$445K 0.01% 123
2024
Q3
$128K Buy
+7,700
New +$128K ﹤0.01% 152